APHAR - Austrian Pharmacological Society - Österreichische Pharmakologische Gesellschaft

GENERAL INFORMATION ABSTRACTS TRAVEL INFORMATION HIGHLIGHTS
GART 2015 SCIENTIFIC PROGRAM SOCIAL EVENTS SPONSORS

21st Scientific Symposium of
the Austrian Pharmacological Society APHAR
Joint meeting with the British Pharmacological Society and the Pharmacological Societies of Croatia, Serbia and Slovenia
Celebrating the 20th Anniversary of APHAR
and the 25th Anniversary of EPHAR
Graz, Austria, 16–18 September 2015
SCIENTIFIC PROGRAM

← download the (preliminary) program
In the program below, abstracts with numbers starting with 'A' are published in Intrinsic Activity, 2015; 3(Suppl.2)
(abstract numbers link to the online publication).
Presentation numbers beginning with 'X' are unpublished presentations.

Download Poster PDF:
Size A4, A3, A2

WEDNESDAY – TALKS THURSDAY – TALKS FRIDAY – TALKS
WEDNESDAY – POSTERS THURSDAY – POSTERS FRIDAY – POSTERS

Poster Session III (Fri 18 Sept; 11:30–13:00)

Group III/1: Chair: Aleksandar L. Rašković (Belgrade)
→ A5.1 The influence of detoxification agents on the intensity of side effects caused by medium-high doses of methotrexate in children with acute lymphoblastic leukemia: case series
Aleksandar L. Rašković, Jovana S. Šumar, Jovanka L. Kolarović, Nada V. Konstantinidis, Boris Ž. Milijašević, Momir M. Mikov and Ana J. Sabo (Novi Sad)
→ A5.2 The role of EGFR mutations in lung cancer: molecular basis of targeted therapy
Vanesa Stepanov, Karmen Stankov, Momir M. Mikov, Milana Panjković, Živka Eri and Branislav Perin (Novi Sad)
→ A5.3 The influence of pretreatment with antioxidants on cytotoxicity of the epigenetic agent vorinostat towards HT-29 colon cancer cells
Nebojša Pavlović, Karmen Stankov, Bojan Stanimirov, Maja Đanić, Vesna Kojić, Gordana Bogdanović and Momir M. Mikov (Novi Sad, Sremska Kamenica)
→ A5.5 The influence of N-acetylcysteine on the cytotoxicity of single-walled carbon nanotubes in human lung carcinoma cells
Nikola Jojić, Vesna Kojić, Danijela Kojić, Karmen Stankov and Gordana Bogdanović (Novi Sad, Sremska Kamenica)
→ A9.1 Interprofessional pharmacology workshop: intervention to close the gap between physicians’ and pharmacists’ attitudes toward their mutual collaboration
Darko Modun, Ana Šešelja Perišin and Arijana Meštrovič (Split)
→ A9.2 Interprofessional students’ pharmacology workshop: intervention to improve health profession students’ attitudes toward physician–pharmacist collaboration
Ana Šešelja Perišin, Arijana Meštrović, Jelena Kačić, Joško Božić and Darko Modun (Split)
→ A9.3 Innovative education and training: a major step forward for Europe through the imi-train initiative
Christa Janko, Mike Hardman, Ingrid Klingmann, Nico P. E. Vermeulen, Annie Fourrier-Réglat and Michael Wolzt (Vienna, Macclesfield, Brussels, Amsterdam, Bordeaux)
→ A9.4 on-course^®: a major upgrade of this course catalogue enhances its service to the biomedical community
Christa Janko, Antony Payton, Rebecca Ludwig, Pavel Dallakian, Mike Hardman and Michael Wolzt (Vienna, Manchester, Braunschweig, Macclesfield)

Group III/2: Chair: Sanja Ćurčić (Graz)
→ A1.17 Ets-2, a possible marker of early instability in coronary artery bypass grafting patients: modulation by drugs
Úrsula Medina, Marta Ramajo, Mónica García Bouza, Fernando Reguillo, Manuel Carnero and Teresa Tejerina (Madrid)
→ A1.19 Rice bran enzymatic extract reduces hyperlipidemia and related hepatic steatosis in ApoE^−/− mice
Cristina Pérez Ternero, María D. Herrera and María Álvarez de Sotomayor (Sevilla)
→ A2.11 The Pro-Gly-containing dipeptidic cognitive enhancer noopept increases the DNA-binding activity of HIF-1
Sergey Seredenin, Julia Vakhitova, Rita Ostrovskaya and Tatyana Gudasheva (Moscow, Ufa)
→ A2.12 Effects of hemantane on the activity of proline-specific endopeptidases in plasma of rats with experimental Parkinson’s disease
Elena Valdman, Elena Ivanova, Nikolay Zolotov, Inga Kapitsa and Tatyana Voronina (Moscow)
→ A2.22 Analgesic action of Androctonus crassicauda venom: evidence for new analgesic peptides
Süleyman Aydın, Ayça Çakmak and Figen Çalışkan (Eskişehir, Kayseri)
→ A2.23 Gender-specific analgesic action of thymol
Ayça Çakmak and Süleyman Aydın (Kayseri, Eskişehir)
→ A6.6 Forensic significance of determination of the alcohol elimination rate through analysis of blood samples at two times
Mensura Aščerić, Svjetlana Loga-Zec and Maida Halilbašić (Tuzla, Sarajevo)

Group III/3: Chair: Georg Wietzorrek (Innsbruck)
→ A3.4 Human bile reduces antimicrobial activity of selected antibiotics against Escherichia coli and Enterococcus faecalis in vitro
David Jaros, Beatrix Wulkersdorfer, Richard Schwameis and Markus Zeitlinger (Vienna)
→ A8.1 Treatment of respiratory tract infections in primary practice: common mistakes in Health Centre Novi Sad
Saša Vukmirović, Ana J. Sabo, Zdenko S. Tomić, Olga J. Horvat, Zoran Bukumirić and Nebojša Stilinović (Novi Sad, Belgrade)
→ A8.2 An analysis of expired medications in Serbian households
Milica M. Paut Kusturica, Ana D. Tomas, Bojana Trivić, Zoran Bukumirić, Zdenko S. Tomić and Ana J. Sabo (Novi Sad)
→ A8.3 Guidelines adherence for prescription of oral antidiabetics in Serbia
Olga J. Horvat, Jelena Popržen, Zdenko S. Tomić and Ana J. Sabo (Novi Sad)
→ A8.4 Use of drugs for the treatment of diabetes mellitus in the Republic of Serbia
Boris Ž. Milijašević, Vedrana Čobanović, Zdenko S. Tomić, Ana Sabo, Dragana Milijašević and Nataša Tomić (Novi Sad)
→ A8.5 Prescription of flunitrazepam in Austria, 2006–2014
Georg Wietzorrek (Innsbruck)
→ A8.6 Prescription and savings potential of RAAS inhibitors in Austria, 2012
Georg Wietzorrek (Innsbruck)
→ A8.7 Nalmefene and concomitant opioid therapy: a systematic analysis of the global WHO pharmacovigilance database
Hendrike Dahmke, Hugo Kupferschmidt, Gerd A. Kullak-Ublick and Stefan Weiler (Zürich)

_________
03.08.2015

GENERAL INFORMATION	ABSTRACTS	TRAVEL INFORMATION	HIGHLIGHTS
GART 2015	SCIENTIFIC PROGRAM	SOCIAL EVENTS	SPONSORS

WEDNESDAY – TALKS	THURSDAY – TALKS	FRIDAY – TALKS
WEDNESDAY – POSTERS	THURSDAY – POSTERS	FRIDAY – POSTERS


	Poster Session III (Fri 18 Sept; 11:30–13:00)

	Group III/1: Chair: Aleksandar L. Rašković (Belgrade)
→ A5.1	The influence of detoxification agents on the intensity of side effects caused by medium-high doses of methotrexate in children with acute lymphoblastic leukemia: case series Aleksandar L. Rašković, Jovana S. Šumar, Jovanka L. Kolarović, Nada V. Konstantinidis, Boris Ž. Milijašević, Momir M. Mikov and Ana J. Sabo (Novi Sad)
→ A5.2	The role of EGFR mutations in lung cancer: molecular basis of targeted therapy Vanesa Stepanov, Karmen Stankov, Momir M. Mikov, Milana Panjković, Živka Eri and Branislav Perin (Novi Sad)
→ A5.3	The influence of pretreatment with antioxidants on cytotoxicity of the epigenetic agent vorinostat towards HT-29 colon cancer cells Nebojša Pavlović, Karmen Stankov, Bojan Stanimirov, Maja Đanić, Vesna Kojić, Gordana Bogdanović and Momir M. Mikov (Novi Sad, Sremska Kamenica)
→ A5.5	The influence of N-acetylcysteine on the cytotoxicity of single-walled carbon nanotubes in human lung carcinoma cells Nikola Jojić, Vesna Kojić, Danijela Kojić, Karmen Stankov and Gordana Bogdanović (Novi Sad, Sremska Kamenica)
→ A9.1	Interprofessional pharmacology workshop: intervention to close the gap between physicians’ and pharmacists’ attitudes toward their mutual collaboration Darko Modun, Ana Šešelja Perišin and Arijana Meštrovič (Split)
→ A9.2	Interprofessional students’ pharmacology workshop: intervention to improve health profession students’ attitudes toward physician–pharmacist collaboration Ana Šešelja Perišin, Arijana Meštrović, Jelena Kačić, Joško Božić and Darko Modun (Split)
→ A9.3	Innovative education and training: a major step forward for Europe through the imi-train initiative Christa Janko, Mike Hardman, Ingrid Klingmann, Nico P. E. Vermeulen, Annie Fourrier-Réglat and Michael Wolzt (Vienna, Macclesfield, Brussels, Amsterdam, Bordeaux)
→ A9.4	on-course^®: a major upgrade of this course catalogue enhances its service to the biomedical community Christa Janko, Antony Payton, Rebecca Ludwig, Pavel Dallakian, Mike Hardman and Michael Wolzt (Vienna, Manchester, Braunschweig, Macclesfield)

	Group III/2: Chair: Sanja Ćurčić (Graz)
→ A1.17	Ets-2, a possible marker of early instability in coronary artery bypass grafting patients: modulation by drugs Úrsula Medina, Marta Ramajo, Mónica García Bouza, Fernando Reguillo, Manuel Carnero and Teresa Tejerina (Madrid)
→ A1.19	Rice bran enzymatic extract reduces hyperlipidemia and related hepatic steatosis in ApoE^−/− mice Cristina Pérez Ternero, María D. Herrera and María Álvarez de Sotomayor (Sevilla)
→ A2.11	The Pro-Gly-containing dipeptidic cognitive enhancer noopept increases the DNA-binding activity of HIF-1 Sergey Seredenin, Julia Vakhitova, Rita Ostrovskaya and Tatyana Gudasheva (Moscow, Ufa)
→ A2.12	Effects of hemantane on the activity of proline-specific endopeptidases in plasma of rats with experimental Parkinson’s disease Elena Valdman, Elena Ivanova, Nikolay Zolotov, Inga Kapitsa and Tatyana Voronina (Moscow)
→ A2.22	*Analgesic action of Androctonus crassicauda* venom: evidence for new analgesic peptides** Süleyman Aydın, Ayça Çakmak and Figen Çalışkan (Eskişehir, Kayseri)
→ A2.23	Gender-specific analgesic action of thymol Ayça Çakmak and Süleyman Aydın (Kayseri, Eskişehir)
→ A6.6	Forensic significance of determination of the alcohol elimination rate through analysis of blood samples at two times Mensura Aščerić, Svjetlana Loga-Zec and Maida Halilbašić (Tuzla, Sarajevo)

	Group III/3: Chair: Georg Wietzorrek (Innsbruck)
→ A3.4	Human bile reduces antimicrobial activity of selected antibiotics against Escherichia coli and Enterococcus faecalis in vitro David Jaros, Beatrix Wulkersdorfer, Richard Schwameis and Markus Zeitlinger (Vienna)
→ A8.1	Treatment of respiratory tract infections in primary practice: common mistakes in Health Centre Novi Sad Saša Vukmirović, Ana J. Sabo, Zdenko S. Tomić, Olga J. Horvat, Zoran Bukumirić and Nebojša Stilinović (Novi Sad, Belgrade)
→ A8.2	An analysis of expired medications in Serbian households Milica M. Paut Kusturica, Ana D. Tomas, Bojana Trivić, Zoran Bukumirić, Zdenko S. Tomić and Ana J. Sabo (Novi Sad)
→ A8.3	Guidelines adherence for prescription of oral antidiabetics in Serbia Olga J. Horvat, Jelena Popržen, Zdenko S. Tomić and Ana J. Sabo (Novi Sad)
→ A8.4	Use of drugs for the treatment of diabetes mellitus in the Republic of Serbia Boris Ž. Milijašević, Vedrana Čobanović, Zdenko S. Tomić, Ana Sabo, Dragana Milijašević and Nataša Tomić (Novi Sad)
→ A8.5	Prescription of flunitrazepam in Austria, 2006–2014 Georg Wietzorrek (Innsbruck)
→ A8.6	Prescription and savings potential of RAAS inhibitors in Austria, 2012 Georg Wietzorrek (Innsbruck)
→ A8.7	Nalmefene and concomitant opioid therapy: a systematic analysis of the global WHO pharmacovigilance database Hendrike Dahmke, Hugo Kupferschmidt, Gerd A. Kullak-Ublick and Stefan Weiler (Zürich)